Oncolytics Operating Cycle from 2010 to 2025

ONCY Stock  USD 0.70  0.01  1.41%   
Oncolytics Biotech Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle is likely to outpace its year average in 2025. During the period from 2010 to 2025, Oncolytics Biotech Operating Cycle regression line of annual values had r-squared of  0.19 and arithmetic mean of  10.56. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
40.44211301
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncolytics Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncolytics Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 88.5 K, Interest Expense of 637.6 K or Selling General Administrative of 19.4 M, as well as many indicators such as Price To Sales Ratio of 66.83, Dividend Yield of 0.0 or PTB Ratio of 5.18. Oncolytics financial statements analysis is a perfect complement when working with Oncolytics Biotech Valuation or Volatility modules.
  
Check out the analysis of Oncolytics Biotech Correlation against competitors.
For more information on how to buy Oncolytics Stock please use our How to Invest in Oncolytics Biotech guide.

Latest Oncolytics Biotech's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Oncolytics Biotech over the last few years. It is Oncolytics Biotech's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncolytics Biotech's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Oncolytics Operating Cycle Regression Statistics

Arithmetic Mean10.56
Geometric Mean0.00
Coefficient Of Variation383.06
Mean Deviation18.95
Median(0)
Standard Deviation40.44
Sample Variance1,636
Range162
R-Value(0.44)
Mean Square Error1,421
R-Squared0.19
Significance0.09
Slope(3.70)
Total Sum of Squares24,533

Oncolytics Operating Cycle History

2013null
2011 3.38
2010 162.15

About Oncolytics Biotech Financial Statements

Oncolytics Biotech investors use historical fundamental indicators, such as Oncolytics Biotech's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncolytics Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Oncolytics Stock Analysis

When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.